According to Cailian Press on July 6th (Editor Ruoyu), the interim report of A-share this week is in full swing. Following the disclosure of the 2024 performance forecast the next day, the net profit of Glory Pharmaceuticals with the highest year-on-year increase in net profit of up to 3.6 times increased by daily limit, as did Kingking Applied Chemistry, Dibay Electric, Olympic Circuit Technology, Elec-Tech International, Baolingbao Biology, Zhejiang Xiantong Rubber&Plastic, Ginlong Technologies, Hualing Cable, and Huahai Pharmaceutical. Linzhou Heavy Machinery, which released its profit forecast on Monday, closed with two consecutive trading limit-ups on Wednesday.

According to incomplete statistics from Cailian Press, as of the publication of this article, a total of 114 A-share listed companies have released performance forecasts for the first half of 2024. Among them, 11 stocks, including Shenzhen Kaizhong Precision Technology, Micro-Tech Endoscopy-U, Will Semiconductor, Montage Technology, Zibo Qixiang Tengda Chemical, Hangzhou Zhongheng Electric, Luxi Chemical Group, Novogene Bioinformatics, COSCO SHIPPING International (Hong Kong) Co., Ltd., Guizhou Qianyuan Power, and Harbin Gloria Pharmaceuticals, are expected to have a year-on-year increase in net profit of up to 300% (see below for specific details). In addition, Zhongjie Resources, Grid Dynamics International, and Fujian Tianma Science and Technology Group are expected to turn losses into profits in the first half of the year.

Specifically, Kaizhong Precision, with the highest growth rate of more than 14 times, still leads the way. The company is expected to have a net profit of 70 million yuan to 90 million yuan in the first half of the year, a year-on-year increase of 1068.44% to 1402.28% (see Cailian Press' previous in-depth report for details: the leading stock has taken three consecutive trading limit-ups! The A-share semi-annual report trend deepens, and the net profit of 8 listed companies has doubled year-on-year). Micro-Tech Endoscopy-U, the domestic leading enterprise in cardiac electrophysiology and the first domestically produced manufacturer capable of providing three-dimensional cardiac electrophysiology equipment and consumable solutions, followed closely with the highest growth rate of 8.28 times. After announcing its performance forecast the next day, its share price rose by more than 11% during intraday trading on Thursday. The company expects to have a net profit of 15 million yuan to 20 million yuan attributable to the owner of the mother company in the first half of 2024, a year-on-year increase of 595.92% to 827.89%. According to calculations, the net profit for Q2 is expected to be 10.8308 million yuan to 15.8308 million yuan, an increase of 160% to 280% compared to the previous quarter. Micro-Tech Endoscopy-U stated that the growth is mainly due to the company's continued deepening of its efforts in the field of cardiac electrophysiology, the optimization of product structure, the increase in the proportion of high-value consumables sales, and the promotion of global market expansion.

Leadtrend Technology, which has a total market value of 65 billion yuan and mainly provides high-performance and low-power chip solutions in the fields of cloud computing and artificial intelligence, announced on Friday after trading that it is expected to record a net profit of 0.583 billion yuan to 0.623 billion yuan in the first half of 2024, an increase of 612.73% to 661.59% year-on-year. Leadtrend Technology stated that on the one hand, the demand for memory interfaces and module supporting chips has shown a rebound since the beginning of this year, with the downstream penetration rate of DDR5 increasing and the iteration of DDR5 sub-generations continuing to advance. In the first half of 2024, the company's second-generation RCD chip shipments had exceeded those of the first-generation RCD chip; on the other hand, some new AI 'traffic' chip products began to be shipped in scale, contributing new growth points for the company's performance. In the secondary market, Leadtrend Technology's stock price has accumulated a maximum increase of 41.44% since April 10th.

Will Semiconductor, with a total market value of 120 billion yuan and a main business of research and design of discrete semiconductor devices and power management IC products, announced after trading on Friday that it is expected to have a net profit of 1.308 billion yuan to 1.408 billion yuan in the first half of 2024, an increase of 754.11% to 819.42% year-on-year. Will Semiconductor pointed out that in the first half of 2024, market demand continued to recover, downstream customer demand increased, and the company's revenue achieved significant growth with the introduction of products in the high-end smart phone market and the continuous penetration of automatic driving applications in the automotive market; in addition, to better respond to the impact of industry fluctuations, the company actively promoted optimization of product structure and supply chain structure, and the company's product gross margin gradually recovered, with significant overall performance improvement.

Zhengzhen Xiang from Founder Securities and others pointed out in a research report on July 5th that in terms of a single quarter, Will Semiconductor achieved revenue of 6.26 billion yuan to 6.54 billion yuan in 2Q24, of which the lower range of revenue of 6.26 billion yuan has surpassed the previous high of 6.24 billion yuan (2Q21), setting a new historical high for a single quarter. This is mainly due to the acceleration of the introduction of mobile phone CIS in the Android high-end market and the continuous penetration of CIS in the automotive market. In terms of profitability, the net profit margin range for 2Q24 is 12%-13%, an increase of 13-14ppts year-on-year and 2-3ppts quarter-on-quarter. The net profit margins for 3Q23/4Q23/1Q24 were 3.4%/3.1%/9.8%, and the profitability improved significantly quarter by quarter with continuous optimization of product structure.

In 2023, the company's overall sales volume of 18,000 kiloliters, +28.10% year-on-year, significant growth. Product structure, 10-30 billion yuan products operating income of 401/1288/60 million yuan respectively.

Hangzhou Zhongheng Electric, one of the major suppliers of domestic communication power systems, announced on Friday evening that its net income for the first half of the year is expected to be between 57 million and 70 million yuan, a year-on-year growth of 423.36%-542.73%. Zhongheng Electric said that as downstream customer construction demand gradually recovers, the company's data center power and software business revenue has grown compared to the same period last year, and the company has strengthened management and operational efficiency, leading to performance growth. Luxi Chemical Group, which has built an integrated industrial chain for the management platform of the intelligent chemical park, announced on Friday evening that its net profit for the first half of the year is expected to be between 1.1 billion and 1.2 billion yuan, a year-on-year growth of 467.04%-518.59%. Luxi Chemical Group stated that during the reporting period, due to various factors such as market supply and demand, some product prices have increased year-on-year while the purchase prices of raw materials have decreased, resulting in an increase of some product gross profits. On the same day, the company and its wholly-owned subsidiary, Peroxide Company, respectively received an administrative penalty decision from the Liao Cheng Emergency Management Bureau, with administrative penalties of 2.08 million yuan and 2 million yuan for the company and Peroxide Company, respectively.

Guizhou Qianyuan Power, which mainly develops, constructs and operates hydropower and thermal power plants in Guizhou region, announced after-hours on Friday that its net profit attributable to shareholders of the listed company is expected to be between 0.118 billion yuan and 0.149 billion yuan in the first half of 2024, a year-on-year increase of 270%-365%. The company stated that the power generation in the first half of the year was 3152.0452 million kilowatt-hours, an increase of 949.4251 million kilowatt-hours, or 43.10%, compared to the same period last year, resulting in an increase in power generation revenue and profit. In the secondary market, Qianyuan Power has a cumulative maximum increase of 50.36% from February 6th to the present.

Harbin Gloria Pharmaceuticals, whose products include cardiovascular and cerebrovascular products, vitamins, and other areas, disclosed its performance forecast after-hours on Tuesday and hit the limit up on the next day. Its net profit for the first half of the year is expected to be between 0.1 billion yuan and 0.13 billion yuan, a year-on-year increase of 253.99%-360.19%. Gloria Pharmaceuticals stated that in the first half of the year, the company continued to promote marketing reforms, and some core product sales achieved rapid growth, such as Annawin/Annastroke and multiple vitamin (B12) injections.